The goal of this clinical trial is to learn whether a 30-day structured wellness program may support physical and emotional well-being in adults who are already taking a GLP-1 or dual GIP/GLP-1 medication for an FDA-approved indication. The study does not evaluate the GLP-1 medication itself or make changes to participants' medication treatment. The main questions it aims to answer are: 1. Are there changes in participants' physical and emotional well-being after completing the 30-day wellness program? 2. Are there changes in areas such as mood, anxiety, functioning, mindfulness, self-compassion, eating-related behaviors, pain, and positive wellness? Participants will: 1. Complete online questionnaires before and after the program. 2. Follow the WILD 5 Wellness program for 30 days, which includes daily practices related to exercise, mindfulness, sleep, social connection, and nutrition. 3. Complete a brief online tracking form each day during the 30-day program.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
200
A 30-day structured wellness program that includes daily practices in five areas: exercise, mindfulness, sleep, social connection, and nutrition. Participants complete the wellness practices independently and complete daily online tracking during the 30-day program.
The GLOW Study
The Colony, Texas, United States
RECRUITINGChange in HERO Wellness Scale Total Score From Baseline to Post-Program
The HERO Wellness Scale is a 5-item self-report measure assessing happiness, enthusiasm, resilience, optimism, and perceived mental wellness. Total scores range from 0 to 50, with higher scores indicating greater mental wellness. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Patient Health Questionnaire-9 (PHQ-9) Total Score From Baseline to Post-Program
The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptom severity. Total scores range from 0 to 27, with lower scores indicating fewer depressive symptoms. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Generalized Anxiety Disorder-7 (GAD-7) Total Score From Baseline to Post-Program
The Generalized Anxiety Disorder-7 (GAD-7) is a 7-item self-report measure of anxiety symptoms. Total scores range from 0 to 21, with lower scores indicating fewer anxiety symptoms. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Brief Pain Inventory Average Pain Score From Baseline to Post-Program
The Brief Pain Inventory Average Pain item is a self-report measure of pain severity. Scores range from 0 to 10, with 0 indicating no pain and 10 indicating pain as bad as the participant can imagine. The outcome will be the change in score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Cognitive and Physical Functioning Questionnaire (CPFQ) Total Score From Baseline to Post-Program
The Cognitive and Physical Functioning Questionnaire (CPFQ) is a 7-item self-report measure of cognitive and physical functioning. Total scores range from 7 to 42, with lower scores indicating better cognitive and physical functioning. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Eating and Appraisal Due to Emotions and Stress (EADES) Total Score From Baseline to Post-Program
The Eating and Appraisal Due to Emotions and Stress (EADES) scale is a self-report measure of emotion- and stress-related eating. Total scores range from 24 to 120, with lower scores indicating greater emotion- and stress-related eating. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Mindful Attention Awareness Scale (MAAS) Total Score From Baseline to Post-Program
The Mindful Attention Awareness Scale (MAAS) is a 15-item self-report measure of mindfulness and attention to present-moment experiences. Total scores range from 15 to 90, with higher scores indicating greater mindfulness. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Sleep Condition Indicator (SCI) Total Score From Baseline to Post-Program
The Sleep Condition Indicator (SCI) is an 8-item self-report measure of sleep problems. Total scores range from 0 to 32, with lower scores indicating greater sleep problems. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Social Connectedness Scale Total Score From Baseline to Post-Program
The Social Connectedness Scale is a self-report measure of perceived social connectedness. Total scores range from 8 to 48, with higher scores indicating greater social connectedness. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in World Health Organization-5 Well-Being Index (WHO-5) Total Score From Baseline to Post-Program
The World Health Organization-5 Well-Being Index (WHO-5) is a 5-item self-report measure of subjective well-being. Total scores range from 0 to 25, with higher scores indicating greater well-being. The outcome will be the change in total score from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
Change in Sheehan Disability Scale (SDS) Scores From Baseline to Post-Program
The Sheehan Disability Scale (SDS) is a self-report measure of functional impairment in work or school, social life, and family life. Each domain is rated from 0 to 10, with higher scores indicating greater functional impairment. The outcome will be the change in SDS scores from pre-program baseline to post-program assessment.
Time frame: Baseline and end of 30-day intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.